Neos Therapeutics, Inc. 8-K SEC Filings

Filed On	Filing
22 Mar 2021	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +6 more
08 Feb 2021	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
11 Jan 2021	8-K: Regulation FD Disclosure
30 Dec 2020	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
11 Dec 2020	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
10 Dec 2020	8-K: Regulation FD Disclosure
09 Nov 2020	8-K: Results of Operations and Financial Condition
10 Aug 2020	8-K: Results of Operations and Financial Condition
19 Jun 2020	8-K: Departure/Election of Directors or Officers; Compensation
11 Jun 2020	8-K: Entry into a Material Definitive Agreement; Submission of Matters to a Vote of Security Holders
03 Jun 2020	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
11 May 2020	8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities
07 May 2020	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
23 Apr 2020	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
09 Apr 2020	8-K: Other Events
30 Mar 2020	8-K: Regulation FD Disclosure; Other Events
13 Mar 2020	8-K: Results of Operations and Financial Condition
08 Nov 2019	8-K: Results of Operations and Financial Condition
03 Oct 2019	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
08 Aug 2019	8-K: Results of Operations and Financial Condition

Comments